Singapore's HiRO snaps up US oncology CRO Courante
06 Sep 2023
Acquisition
Preview
Source: FierceBiotech
Singapore-based Harvest Integrated Research Organization acquired U.S.-based Courante Oncology as consolidation in the CRO space continues.
Singapore-based Harvest Integrated Research Organization, or HiRO, has expanded its global footprint with the acquisition of Courante Oncology, a Minnesota-based CRO that specializes in oncology.
The deal represents a big step for HiRO in establishing itself as a global player, the company said in an Aug. 31 press release. Financial terms of the deal weren’t disclosed.
Courante, which has been in the drug development arena for more than 25 years, has experience in phase 1-3 clinical trials, including initial feasibility studies, protocol development, site monitoring and closeout visits.
Consolidation within the CRO industry continues unabated. In recent weeks, RQM+ acquired German CRO Kottmann, Sygnature Discovery purchased NuChem Sciences, Frontage Labs picked up Nucro-Technics and Kohlberg & Co. bought Worldwide Clinical Trials.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.